These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 17318447)
41. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice. Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522 [TBL] [Abstract][Full Text] [Related]
42. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring. Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741 [TBL] [Abstract][Full Text] [Related]
43. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323 [TBL] [Abstract][Full Text] [Related]
44. Re: High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms. Selvaraj RJ; Chauhan VS Heart Rhythm; 2008 Nov; 5(11):e5-6; author reply e6. PubMed ID: 18783997 [No Abstract] [Full Text] [Related]
45. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate. Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268 [TBL] [Abstract][Full Text] [Related]
47. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator]. Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942 [TBL] [Abstract][Full Text] [Related]
48. The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy. O'Mahony C; Lambiase PD; Rahman SM; Cardona M; Calcagnino M; Quarta G; Tsovolas K; Al-Shaikh S; McKenna W; Elliott P Europace; 2012 May; 14(5):724-33. PubMed ID: 22094454 [TBL] [Abstract][Full Text] [Related]
49. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia. Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696 [TBL] [Abstract][Full Text] [Related]
50. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928 [TBL] [Abstract][Full Text] [Related]
51. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Spencker S; Coban N; Koch L; Schirdewan A; Müller D Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654 [TBL] [Abstract][Full Text] [Related]